Navigation Links
Cancer researchers add spice to research against rare neuromuscular disease

Scientists who focus on the molecular signaling that underlies prostate cancer have discovered a compound that shows promise against a debilitating neurodegenerative condition known as Kennedy's disease, which is caused by a mutant gene. Currently there is no treatment for the inherited disorder, which resembles a slowly progressive form of Lou Gehrig's disease and affects only men.

The compound, a distant chemical relative of a component of the spice curry, dramatically slowed the progression of the disease in mice that carried the mutant human gene that causes the disease. The mice were able to walk much more normally, their muscles were much stronger, and they had near-normal levels of a vital molecule crucial for keeping nerve cells healthy.

While a great deal more research needs to be done to see if the compound could be developed into a drug to help people with the disease, scientists say it's a promising development in a field where progress has been slow.

The research by scientists at the University of Rochester Medical Center appears in the March 6 issue of the journal Nature Medicine.

In their search for new treatments for prostate cancer and other diseases, Chawnshang Chang, Ph.D., and his colleagues have taken a few cues from centuries of Asian tradition, where curcumin ?the bright yellow spice found in curry powder ?has been used to treat a variety of ills. In the last decade, Western medicine has been putting curry to the test, finding that the spice offers promise against breast cancer, melanoma, Alzheimer's disease and the blisters that come with radiation treatments for cancer.

Chang notes that ginger, a family of spices that includes curcumin, is widely used in China as a folk medicine to treat male-pattern baldness. That condition is caused largely by the activity of the androgen receptor, the protein that is central to the action of testosterone and other male hormones. Chang's laboratory, in collabo
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3 4

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Jump-starting T Cells In Skin Cancer
3. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Breakthrough Microarray-based Technology for the Study of Cancer
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
8. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
9. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
10. New Breast Cancer Test Could Save Lives
11. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells

Post Your Comments:
(Date:11/4/2009)...g Beach and Riverside are responsible for a signif...and the true impact of air pollution and ship emis...d, according to researchers at the University of S...pears in an online edition of the American Journa...f all childhood asthma cases in Long Beach and six...
(Date:11/4/2009)..., hold the power to help militaries and munitions ...ic waste on test sites. , Compounds known as nit...orld War II and have been used in military munitio...ften used to propel tank shells and act like a mor...d knowledge of their environmentally harmful effec...
(Date:11/4/2009)...eived more than $10 million in research grants fro...mulus program, bringing thetotal amount of stimulu...n. Thirty-three projects achieved stimulus fundin... , "The university has thoughtfully undertaken a... excellence to federal agency priorities. Through...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 1Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 2Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 3VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
... The next time you mutter about the high cost of r...hat microbes share your pain. In the first study ...ping Xu, associate professor of biology at McMaste...hological and behavioural stress on microbes. His ...netics, published by the Genetics Society of Ameri...
... Some HIV medications lead to the development of d... percent of their medications. For other medicatio... of their pills. These differences appear to be ex... of the drug-resistant HIV, say AIDS researchers i...erg, MD, MPH, an AIDS specialist at the University...
... A more accurate method for measuring blood levels...tream and repair damage to the arterial lining has... cardiologists. These cells, known as endothelial ...arrow and travel to the site of arterial damage. ,... used to assess a patient,s degree of coronary art...
Other Biology News:Sex: It's costly but worth it. Just ask a microbe 2Viral 'fitness' explains different resistance patterns to aids drugs 2Measuring artery repair cells could become new heart disease test 2Measuring artery repair cells could become new heart disease test 3
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) ...ng at the following investor conferences, and invi... Credit Suisse Healthcare Conference, P... 2009 at 10 a.m. Mountain Time, N... Tuesday, 1 December, 2009 at 10.45...
(Date:11/5/2009)...Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone...he "Company") today announced,that the Company pla... on,Monday, November 9, 2009, after the market clo... call at 5:00 pm ET on November 9, 2009,to discuss... the call by,dialing 1-888-713-4211 or 1-617-213-4...
(Date:11/4/2009)...an Anthrax Vaccine Program must be stopped. Scott... "A Call to Arms:2009 Edition" and the o...y: The Human Anthrax Vaccine Story" to inform...top secret government science turned into for-prof...o its victims. It is available for world-wide lic...
(Date:11/4/2009)... Nektar Therapeutics (Nas...for the third quarter ended September 30, 2009. ,...2009 improved to $31.0 million or $0.33 per share,...40 per share in the third quarter of 2008. ,...rating efficiencies as compared to a year ago. To...
Breaking Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...lif., May 8 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... Bank of America Health Care Conference on Thursda...parties may access a live webcast of the,presentat...wt/page/event_calendar , It is recommended that l...ter and download any necessary software. For those...
... Calif., May 8 Beckman Coulter,Inc. (NYSE: BEC )...of,products that simplify, automate, and innovate ...ul Glyer, Beckman Coulter,s Senior Vice President,... the following,conferences:, (Logo: http://ww... Bank of America 2008 Healthcare Conference on Wed...
...., May 8 BioSpace, the world,s leading,online bio...pany, unveiled,this morning the 2008 Bio NC(TM) Ho... Carolina., (Photo: http://www.newscom.com/cgi-b...ewscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), T...pharmaceutical and,medical device communities in R...
Other Biology Technology:Beckman Coulter to Present at Upcoming Healthcare Conferences 2BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign 2
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Goat Anti-SPFH2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Als2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: